4//SEC Filing
Maloberti Renaud Bertrand 4
Accession 0001209191-19-060088
CIK 0001681682other
Filed
Dec 10, 7:00 PM ET
Accepted
Dec 11, 5:50 PM ET
Size
5.5 KB
Accession
0001209191-19-060088
Insider Transaction Report
Form 4
Maloberti Renaud Bertrand
Chief Commercial Officer
Transactions
- Award
Stock option (right to buy)
2019-12-11+42,859→ 42,859 totalExercise: $0.90Exp: 2029-12-11→ Common Stock (42,859 underlying)
Footnotes (1)
- [F1]These options vest and become exercisable in three equal annual installments beginning on the one year anniversary of the grant date.
Documents
Issuer
ENDRA Life Sciences Inc.
CIK 0001681682
Entity typeother
Related Parties
1- filerCIK 0001744025
Filing Metadata
- Form type
- 4
- Filed
- Dec 10, 7:00 PM ET
- Accepted
- Dec 11, 5:50 PM ET
- Size
- 5.5 KB